Using near-infrared spectroscopy, we examined changes in the concentration of oxygenated hemoglobin ([oxyHb]) in the frontal lobe during a verbal fluency task in 20 patients with schizophrenia (10 patients each receiving olanzapine [OLZ] and risperidone [RIS]) and 10 healthy controls. We found that [oxy-Hb] levels in the prefrontal region were higher in the patients receiving OLZ than in those receiving RIS. These results suggest that antipsychotic drugs have different effects on cerebral hemodynamic patterns, which may reflect frontal lobe function. Further studies with a larger sample size are needed to verify our preliminary findings.
Introduction
Impaired cognitive function plays a major role in psychiatric disorders such as schizophrenia (SC) (Censits et al., 1997; Heaton et al., 2001) . A meta-analysis of 36 studies that examined abnormal cerebral metabolism in patients with SC found a decrease in frontal lobe function that became more pronounced as the duration of the disorder increased (Davidson and Heinrichs, 2003; Hill et al., 2004) . On the other hand, mounting evidence shows that these atypical antipsychotics improve cognitive function (Keefe et al., 1999 (Keefe et al., , 2004 (Keefe et al., , 2006 Potkin et al., 2001) .
Several studies have reported that atypical antipsychotics increase dopamine release in the prefrontal cortex (Kuroki et al., 1999; Gessa et al., 2000; Ichikawa et al., 2001; Heidbreder et al., 2001) , which may lead to improved cognitive function in patients with SC (Kumari et al., 2015) . Although the improvement in cognitive function brought by antipsychotics varies with each medication (Wang et al., 2013) , the effects of atypical antipsychotics on cerebral function in the frontal lobe remain unknown.
Near-infrared spectroscopy (NIRS) is a noninvasive and useful method that measures only the function of the cerebral cortex, not deep tissue, and has a high temporal resolution (0.1 s). Recent reviews have found that activation during a variety of frontal lobe tasks is lower in patients with SC than in healthy controls (HCs) (Pu et al., 2016; Itakura et al., 2017) .
Therefore, in the present study, to clarify the differential effects of antipsychotics on frontal lobe function, we compared brain function in patients with SC who were receiving olanzapine (OLZ), a multi-acting receptor-targeted antipsychotic, or risperidone (RIS), a serotonin-dopamine antagonist, with HCs using NIRS.
Methods

Participants
The study participants were 20 non-randomized, non-consecutive inpatients and outpatients with SC treated with OLZ (n = 10) or RIS (n = 10), as well as 10 HCs who were matched for age (Supplementary Table 1 ). SC was diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition. All diagnoses were made by two experienced psychiatrists, and the comorbidity of mental illness was ruled out for all participants. All participants were right-handed (score > 70), according to the Edinburgh Handedness Inventory (Oldfield, 1971) . The clinical symptoms of SC were evaluated by trained psychiatrists using the Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987) on the same day as the NIRS sequences. This study was approved by the ethics committee of Fukushima Medical University, and all patients provided their consent to participate after
